Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of Managed Care & Specialty Pharmacy|April 28, 2021
DISCARDED MEDICATIONS IN VIALS ARE A SYMPTOM OF OUR HEALTH CARE SYSTEM: A CALL TO ACTIONJonathan H Watanabe, Tracy Lieu, Edward H Shortliffe
Health Affairs (Project Hope)|January 9, 2013
The experience of Massachusetts shows that consumers will need help in navigating insurance exchangesAnna D Sinaiko, Dennis Ross-Degnan, Stephen B Soumerai, et al.
Public Health Reports (Washington, D.C. : 1974)|March 15, 2006
Parental perspectives on influenza vaccination among children with asthmaSangeeth K Gnanasekaran, Jonathan A Finkelstein, Katherine Hohman, et al.
The Journal of Infectious Diseases|May 3, 2008
An economic analysis of the universal varicella vaccination program in the United StatesFangjun Zhou, Ismael R Ortega-Sanchez, Dalya Guris, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 27, 2002
Health-related quality of life and future health care utilization for asthmaMark D Eisner, Lynn M Ackerson, Felicia Chi, et al.
Health and Quality of Life Outcomes|February 18, 2017
The impact of preterm birth <37 weeks on parents and families: a cross-sectional study in the 2 years after discharge from the neonatal intensive care unitAshwini Lakshmanan, Meghana Agni, Tracy Lieu, et al.
Pediatrics|April 5, 2012
Measles-containing vaccines and febrile seizures in children age 4 to 6 yearsNicola P Klein, Edwin Lewis, Roger Baxter, et al.
EGEMS (Washington, DC)|May 4, 2016
Building a Governance Strategy for CER: The Patient Outcomes Research to Advance Learning (PORTAL) Network ExperienceAndrea R Paolino, Elizabeth A McGlynn, Tracy Lieu, et al.
Health Affairs (Project Hope)|November 7, 2012
Success of program linking data sources to monitor H1N1 vaccine safety points to potential for even broader safety surveillanceDaniel Salmon, W Katherine Yih, Grace Lee, et al.
Clinical Therapeutics|April 30, 2015
Asthma Treatments and Mental Health Visits After a Food and Drug Administration Label Change for Leukotriene InhibitorsChristine Y Lu, Fang Zhang, Matthew D Lakoma, et al.
Pageof 2